Connect with us


Portugal: GreenBe Pharma obtains EuGMP certification at Elvas facilities



A GreenBe Pharma, a medicinal cannabis company located in Elvas, Portugal, has obtained EU-GMP certification, under the European Union's Good Manufacturing Practices regulations, the company announced in a press release. The first batches of EU-GMP compliant products will be available this spring, allowing GreenBe to process pharmaceutical-grade cannabis flowers for international markets. Compliance with EU GMP rules is mandatory for international trade and demonstrates that the company adheres to global pharmaceutical standards, making this certification an important milestone for GreenBe Pharma, which has around 10.000 m2 designed for growing cannabis plants , GreenBe Pharma uses high-tech greenhouses under energy-efficient processes and sustainable practices. The facilities have operated since their foundation under GACP Standards, Good Agricultural and Harvest Practices, which was also certified by Infarmed, in September 2023. At its Elvas unit, GreenBe includes 19 independent cultivation chambers, each with its own climate control capabilities. Furthermore, the processing facility that has achieved EU-GMP certification will enable a maximum processing capacity of up to four tonnes of dried cannabis flowers annually in the form of Active Pharmaceutical Ingredients (API) to serve national and international markets. The company also announced that it has developed and is currently fulfilling cultivation and manufacturing agreements with pharmaceutical and distribution companies to distribute its medical cannabis products in Portugal, Germany, the United Kingdom, Australia and other international markets, ensuring patient access to prescriptions in pharmacies. This achievement represents a significant milestone for GreenBe Pharma, as these are currently some of the fastest growing markets for medical cannabis globally. Over the past 18 months, GreenBe has invested in its cultivation and manufacturing capabilities to ensure that its products meet the quality requirements of its partners and meet the strictest standards of international regulations. João Janeiro, operations director at GreenBe Pharma, stated that “achieving this important milestone for us was possible thanks to the efforts of the company that provides the means and resources to build the most efficient and robust medical cannabis production system in Portugal”. At GreenBe Pharma there is a clear vocation for highly efficient agricultural production, right from the project's conception. “We have been growing other valuable crops for six generations and we will focus on what we are good at: growing the highest quality plants, from the best breeding programs in the world, that the patient-oriented market demands,” said João Janeiro. Eliecer Lopez, business development manager at GreenBe Pharma, said that “after the entire complex was built and operational in just 11 months, obtaining Infarmed accreditation for EU-GMP has been one of the most challenging parts of the entire project. process. However, the time since construction has allowed us to test and select a wide range of genetics for different purposes and to test and fine-tune state-of-the-art facilities to achieve operational excellence.” The customer-focused strategy, according to the company, aims to provide innovative products to patients around the world. GreenBe Pharma has designed a portfolio of cultivars to combine higher THC products with popular varieties balanced with exceptional terpenoid profiles. “The production and quality assurance team have done an excellent job, ensuring that any flower harvested and processed at our Elvas facility since July 2023, with passion and attention to detail, will comply with EU GMP standards.



[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]


What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

+ posts
Click here to comment
Notify of

Inline feedback
View all comments

Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Events1 hours ago

CannaTrade returns to Zurich from May 24th to 26th

CannaTrade – Zurich International Hemp Fair and Festival comes of age in 2024, celebrating its 18th...

Press Releases2 days ago

SOMAÍ Group and its subsidiary RPK Biopharma expand partnership with Cookies to include Europe and the United Kingdom

LISBON, PORTUGAL, May 16, 2024 / — The SOMAÍ Group (“SOMAÍ”) and its subsidiary, RPK Biopharma expanded...

National5 days ago

Portugal: Estimated CBD consumption increases despite ban

The “Cannabis in Portugal” report, carried out by Euromonitor International, released the most recent data on the cannabis industry,...

National6 days ago

"Cannabis. Maldita e Maravilhosa”, by Margarita Cardoso de Meneses, hits bookstores on May 16th

Margarita Cardoso de Meneses, contributor to CannaReporter®, has just published the book “Canábis. Maldita e Maravilhosa”, published by Oficina do...

Press Releases1 weeks ago

Montemor-o-Velho: Arrested for cannabis cultivation

The Coimbra Territorial Command, through the Criminal Investigation Unit (NIC) of the Montemor-o-Velho Territorial Detachment, today, the 9th...

Events1 weeks ago

PTMC – Portugal Medical Cannabis brings together the medical cannabis industry on May 22nd, in Lisbon

PTMC – Portugal Medical Cannabis will bring together professionals from the medical cannabis industry on the 22nd of...

corporations1 weeks ago

USA: MedMen declares bankruptcy with 400 million dollars of debt

US cannabis giant MedMen collapsed under the weight of its debt, announcing last week that...

News2 weeks ago

Study reveals that legalization of cannabis does not increase consumption of other substances

One of the most used arguments against the legalization of cannabis for adult or recreational use has been the idea of...

Hemp2 weeks ago

Latvia: Obelisk Farm's Hemp School is a finalist for the 2024 EFT Green Skills Award

Obelisk Farm continues to be recognized around the world for its unique approach to the exploitation of industrial hemp. The family project, which...

Events2 weeks ago

USA: CannMed 24 Innovation & Investment Summit returns to Marco Island, Florida, from May 12th to 15th

It is one of the most important scientific conferences on the medical cannabis industry and returns to Marco Island, Florida,...